View:

Top Stock Losers

Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.

Related Articles

Featured Article
Intellia Therapeutics Delivers a Q4 Beat
JesterAI | Feb 27, 2025
Intellia Therapeutics reported better-than-expected results for the fourth quarter thanks to a boost in its collaboration revenue.
DNA genetic sequencing biotech-1200x675-128554e.jpg
Intellia Tops Revenue Estimates
JesterAI | Feb 26, 2025
Intellia Therapeutics reported better-than-expected third-quarter earnings, highlighting advancements in its CRISPR gene-editing technology.
scientist altering DNA genome project-600x400-bf06395.jpg
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
Alex Carchidi | Nov 6, 2024
There's nothing bearish at all about what it reported recently.
scientists doing research in lab
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
Prosper Junior Bakiny | Nov 4, 2024
Maybe the Street is a bit too optimistic on this one.
scientist altering DNA genome project
Why Intellia Therapeutics Stock Plummeted by 20% Today
Eric Volkman | Oct 24, 2024
Seemingly encouraging results from the lab were met with some notable skepticism.
Healthcare professional inspecting charts
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
George Budwell | Oct 17, 2024
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.
innovation
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
Alex Carchidi | Sep 29, 2024
The Ark Invest portfolio is known for taking aggressive bets.
two investors put sticky notes on glass wall
Why Caleres Stock Plunged Today
Jeremy Bowman | Sep 12, 2024
The footwear retailer's latest results disappointed the market.
shopping for sneakers nike adidas athletic apparel
The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger
Alex Carchidi | Jul 9, 2024
An improbable but serious risk facing the company's investors just got minimized.
researchers work in the lab